首页> 外文OA文献 >OP009 Long-term safety and efficacy of golimumab in patients with moderately to severely active ulcerative colitis: Results from the PURSUIT-SC Maintenance study extension

【2h】

OP009 Long-term safety and efficacy of golimumab in patients with moderately to severely active ulcerative colitis: Results from the PURSUIT-SC Maintenance study extension

机译：OP009患者中适度到严重活跃的溃疡性结肠炎患者的长期安全性和功效：追踪-SC维护研究延伸的结果

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

页面导航

著录项
相似文献
相关主题

著录项

作者
W. Reinisch; P. Gibson; W.J. Sandborn; B.G. Feagan; C. Marano; R. Strauss; J. Johanns; H. Zhang; L. Padgett; J.-F. Colombel; J. Collins; P. Rutgeerts;
展开▼
作者单位

展开▼
年度 2014
总页数
原文格式 PDF
正文语种
中图分类

相似文献

外文文献
中文文献
专利

1. Maintenance of Efficacy and Continuing Safety of Golimumab for Active Ulcerative Colitis: PURSUIT-SC Maintenance Study Extension Through 1 YearOpen [J] . Peter R Gibson, Brian G Feagan, William J Sandborn, Clinical and Translational Gastroenterology . 2016,第4期

机译：维持戈利木单抗治疗活动性溃疡性结肠炎的功效和持续安全性：PURSUIT-SC维持研究延长至1年
2. Long-Term Benefit of Golimumab for Patients with Moderately to Severely Active Ulcerative Colitis: Results from the PURSUIT-Maintenance Extension [J] . Reinisch Walter, Gibson Peter R., Sandborn William J., Journal of Crohn’s & colitis . 2018,第9期

机译：Golimalab对患者的长期益处，适度到严重活跃的溃疡性结肠炎：追求 - 维护延伸的结果
3. Efficacy and safety of golimumab 52-week maintenance therapy in Japanese patients with moderate to severely active ulcerative colitis: a phase 3, double-blind, randomized, placebo-controlled study-(PURSUIT-J study) [J] . Toshifumi Hibi, Yuya Imai, Asako Senoo, Journal of gastroenterology . 2017,第10期

机译：戈尔单抗52周维持治疗的疗效和安全性中度患者中度至严重活性溃疡性结肠炎：阶段3，双盲，随机，安慰剂对照研究 - （追求-J学习）
4. Synbiotic Therapy Significantly Reduces Molecular Markers of Inflammation and Clinical Scores in Patients with Active Ulcerative Colitis; A Randomised Controlled Trial [C] . Controlled Release Society annual meeting . 2004

机译：同步治疗显着减少了活性溃疡性结肠炎患者的炎症和临床评分的分子标记;随机对照试验
5. Long-Term Outcomes of Immunosuppression-Na?ve Steroid Responders following Hospitalization for Acute Severe Ulcerative Colitis [D] . Vedamurthy, Amar. 2018

机译：免疫抑制-NA've类固醇响应者的长期结果，治疗急性严重溃疡性结肠炎
6. Maintenance of Efficacy and Continuing Safety of Golimumab for Active Ulcerative Colitis: PURSUIT-SC Maintenance Study Extension Through 1 Year [O] . Peter R Gibson, Brian G Feagan, William J Sandborn, 2016

机译：戈利木单抗治疗活动性溃疡性结肠炎的功效和持续安全性：PURSUIT-SC维持研究延长了一年
7. Efficacy and safety of golimumab 52-week maintenance therapy in Japanese patients with moderate to severely active ulcerative colitis: a phase 3, double-blind, randomized, placebo-controlled study-(PURSUIT-J study) [O] . Toshifumi Hibi, Yuya Imai, Asako Senoo, 2017

机译：Golimumab 52周维持疗法对日本中度至重度活动性溃疡性结肠炎患者的疗效和安全性：一项三期，双盲，随机，安慰剂对照研究-（PURSUIT-J研究）

OP009 Long-term safety and efficacy of golimumab in patients with moderately to severely active ulcerative colitis: Results from the PURSUIT-SC Maintenance study extension

著录项

相似文献

相关主题

期刊订阅